Literature DB >> 6221976

T lymphocyte subsets in inflammatory bowel disease: peripheral blood.

W S Selby, D P Jewell.   

Abstract

Peripheral blood T lymphocytes and T lymphocyte subsets have been quantified in 28 patients with ulcerative colitis and 26 with Crohn's disease by an indirect immunofluorescence technique using monoclonal antibodies: OKT3, which detects all peripheral blood T lymphocytes; OKT4 (T cells of helper phenotype); and OKT8 (T cells of supressor-cytotoxic phenotype). Eighteen normal subjects and 16 patients with a variety of non-inflammatory gastrointestinal disorders were studied as controls. No significant differences were found between patient and control groups in the proportions of circulating T lymphocytes or their subsets. When compared with normal subjects, absolute numbers of T lymphocytes were reduced in patients with active ulcerative colitis or Crohn's disease (p less than 0.05). OKT4+ T cell numbers were reduced in ulcerative colitis, whether active (p less than 0.02) or inactive (p less than 0.05) and in active Crohn's disease (p less than 0.05) Numbers of OKT8+ T cells were reduced in active Crohn's disease (p less than 0.01). There were no differences in T lymphocyte numbers between the patient groups and the disease control subjects. The OKT4+:OKT8+ ratio in patients with inflammatory bowel disease did not differ from that in controls. No relation was found between any of the parameters studied and disease activity, site, or extent of disease, or treatment with sulphasalazine or corticosteroids. The presence of Ia-like, HLA-DR antigens on T cells was detected using a double marker immunofluorescence technique. In control subjects up to 7% of OKT3+ cells were HLA-DR+. In only three patients was the proportion of HLA-DR+ cells greater than in controls. These results indicate that the pathogenesis of ulcerative colitis or Crohn's disease does not depend upon an alteration in the proportion of circulating T lymphocytes nor upon an imbalance of T lymphocyte subsets as defined by monoclonal antibodies. The reduction in T lymphocyte numbers may result from mucosal infiltration. The findings also suggest that circulating T lymphocytes are not activated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221976      PMCID: PMC1420167          DOI: 10.1136/gut.24.2.99

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  T and B lymphocytes and cutaneous anergy in inflammatory bowel disease.

Authors:  D B Sachar; R N Taub; K Ramachandar; S Meyers; S P Forman; S D Douglas; H D Janowitz
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  The subpopulations of circulating white blood cells in inflammatory bowel disease.

Authors:  W R Thayer; C Charland; C E Field
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

3.  The sheep-cell rosette: test on human peripheral blood lymyphocytes: an analysis of some analysis of some variable factors in the technique.

Authors:  C M Steel; J Evans; M A Smith
Journal:  Br J Haematol       Date:  1974-10       Impact factor: 6.998

4.  Peripheral blood T and B cells in chronic inflammatory bowel disease.

Authors:  R G Strickland; S Korsmeyer; R D Soltis; I D Wilson; R C Williams
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

5.  Imparied lymphocyte responsiveness in inflammatory bowel disease.

Authors:  D B Sachar; R N Taub; S M Brown; D H Present; B I Korelitz; H D Janowitz
Journal:  Gastroenterology       Date:  1973-02       Impact factor: 22.682

6.  No evidence for decreased lymphocyte reactivity in Crohn's disease.

Authors:  A G Bird; S Britton
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

7.  Lymphocyte responses to nonspecific mitogens in inflammatory bowel disease.

Authors:  P Asquith; S C Kraft; R M Rothberg
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

8.  Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease.

Authors:  R G Strickland; G Husby; W C Black; R C Williams
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

9.  Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations.

Authors:  S G Meuwissen; T M Feltkamp-Vroom; A B De La Rivière; A E Von Dem Borne; G N Tytgat
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

10.  Short-term course and prognosis of Crohn's disease.

Authors:  F T De Dombal; I L Burton; S E Clamp; J C Goligher
Journal:  Gut       Date:  1974-06       Impact factor: 23.059

View more
  27 in total

1.  Antigen induced suppression in peripheral blood and lamina propria mononuclear cells in inflammatory bowel disease.

Authors:  H R Dalton; P Hoang; D P Jewell
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 2.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Mononuclear cells in peripheral venous blood of patients with Crohn's disease: preoperative status and postoperative course, influence of duration, activity and extent of disease.

Authors:  G Schürmann; M Betzler; B von Ditfurth; U Abel; C Herfarth
Journal:  Langenbecks Arch Chir       Date:  1991

4.  Impaired regulation of natural killer cells in immunoglobulin synthesis by peripheral blood mononuclear cells from patients with ulcerative colitis.

Authors:  T Kawase; K Kusugami; H Matsunaga; T Matsuura; K Morise
Journal:  Gastroenterol Jpn       Date:  1990-10

5.  Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease.

Authors:  M Senju; F Hulstaert; J Lowder; D P Jewell
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

6.  Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.

Authors:  F Pallone; S Fais; O Squarcia; L Biancone; P Pozzilli; M Boirivant
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

7.  Isolation of intestinal mononuclear cells: factors released which affect lymphocyte viability and function.

Authors:  P R Gibson; A Hermanowicz; H J Verhaar; D J Ferguson; A L Bernal; D P Jewell
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

8.  Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors.

Authors:  A Raedler; S Fraenkel; G Klose; H G Thiele
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Immune status in healthy relatives of patients with familial Crohn's disease.

Authors:  A Van Gossum; E Dupont; L Schandene; M Cremer; J Wybran
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

10.  Crohn's disease and myasthenia gravis: a possible role for thymectomy.

Authors:  I A Finnie; R Shields; R Sutton; R Donnelly; A I Morris
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.